Um-PEA/Baic treatment, more than um-PEA administration alone, reduced IKB-α degradation (Figure 5A) and consequently nuclear translocation of NF-κB (Figure 5C) induced by BPH damage. Here, NFKB1 is linked to benign prostatic hyperplasia.